Barclays PLC Novo Nordisk A S Call Options Transaction History

Barclays PLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $45.4 Million - $54.4 Million	370,000 New	370,000 $52.8 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $11 Million - $14.5 Million	107,500 New	107,500 $14.5 Million
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $1.93 Million - $2.53 Million	-39,100 Reduced 68.24%	18,200 $1.1 Million
Q4 2019 Feb 10, 2020	SELL	$49.86 - $58.26 $613,278 - $716,598	-12,300 Reduced 17.67%	57,300 $3.32 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $1.53 Million - $1.72 Million	32,200 Added 86.1%	69,600 $3.6 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $102,938 - $115,434	2,200 Added 6.25%	37,400 $1.91 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $880,840 - $999,970	-19,000 Reduced 35.06%	35,200 $1.84 Million
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $689,564 - $784,350	16,600 Added 44.15%	54,200 $2.5 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $706,076 - $773,724	-15,100 Reduced 28.65%	37,600 $1.77 Million
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $13.7 Million - $15.6 Million	-310,300 Reduced 85.48%	52,700 $2.43 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $15.5 Million - $18.6 Million	320,500 Added 754.12%	363,000 $17.9 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $1.41 Million - $1.59 Million	-29,600 Reduced 41.05%	42,500 $2.28 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $2.97 Million - $3.55 Million	72,100	72,100 $3.47 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.